Obesity Surgery

, 17:679

First online:

Impact of Laparoscopic Adjustable Gastric Banding on Obesity Co-morbidities in the Medium- and Long-Term

  • M. KorenkovAffiliated withDepartment of Surgery, University of MainzDepartment of Abdominal Surgery, University of Mainz Email author 
  • , S. ShahAffiliated withDepartment of Surgery, University of Mainz
  • , S. SauerlandAffiliated withInstitute for Research in Operative Medicine, University of Witten/Herdecke
  • , F. DuenschedeAffiliated withDepartment of Surgery, University of Mainz
  • , Th. JungingerAffiliated withDepartment of Surgery, University of Mainz

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


The authors evaluated the impact of laparoscopic adjustable gastric banding (LAGB) on obesity-associated diseases in a series at 3 to 8 years postoperatively, namely diabetes, pulmonary disease, hypertension and knee joint pain.


145 morbidly obese patients underwent LAGB with mean age 38 years and preoperative BMI 48.5 kg/m2 (range 34–7). Changes in BMI and excess BMI loss (EBL) were evaluated.


138 of the 145 patients (95%) were available for full follow-up. At last follow-up, BMI had dropped to 34.0 ±–.4 SD kg/m2, and mean EBL was 61.9 ±–6.1%. Prevalence of obesity-associated disease was significantly reduced: diabetes decreased from 10% to 4%, treatment-requiring pulmonary disease from 15% to 5%, hypertension from 43% to 27%, and knee pain from 47% to 38%.


Following gastric banding, >75% of patients suffering from obesity-related disease had significant decrease or resolution of their co-morbidities.

Key words

Morbid obesity obesity surgery laparoscopic gastric banding obesity-associated diseases